These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24757114)

  • 1. Cognitive impairment and dementia in Parkinson's disease: practical issues and management.
    Emre M; Ford PJ; Bilgiç B; Uç EY
    Mov Disord; 2014 Apr; 29(5):663-72. PubMed ID: 24757114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: a review.
    Leroi I; Collins D; Marsh L
    J Neurol Sci; 2006 Oct; 248(1-2):104-14. PubMed ID: 16806271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
    Drach LM
    Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment and dementia in Parkinson's disease.
    Marder K
    Mov Disord; 2010; 25 Suppl 1():S110-6. PubMed ID: 20187235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.
    Goetz CG; Emre M; Dubois B
    Ann Neurol; 2008 Dec; 64 Suppl 2():S81-92. PubMed ID: 19127578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tools of the trade: a state of the art "How to Assess Cognition" in the patient with Parkinson's disease.
    Marras C; Tröster AI; Kulisevsky J; Stebbins GT
    Mov Disord; 2014 Apr; 29(5):584-96. PubMed ID: 24757108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiology of cognitive impairment in Parkinson's disease.
    Jellinger KA
    Expert Rev Neurother; 2012 Dec; 12(12):1451-66. PubMed ID: 23237352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Parkinson's disease dementia : practical considerations.
    Rongve A; Aarsland D
    Drugs Aging; 2006; 23(10):807-22. PubMed ID: 17067184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study.
    Zangaglia R; Pacchetti C; Pasotti C; Mancini F; Servello D; Sinforiani E; Cristina S; Sassi M; Nappi G
    Mov Disord; 2009 Aug; 24(11):1621-8. PubMed ID: 19514093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?
    Vale S
    Exp Biol Med (Maywood); 2008 Aug; 233(8):941-51. PubMed ID: 18535172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.
    Witt K; Daniels C; Reiff J; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    Lancet Neurol; 2008 Jul; 7(7):605-14. PubMed ID: 18538636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive and neuropsychiatric disorders in Parkinson's disease].
    Rodríguez-Constenla I; Cabo-López I; Bellas-Lamas P; Cebrián E
    Rev Neurol; 2010 Feb; 50 Suppl 2():S33-9. PubMed ID: 20205140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive change in Parkinson disease.
    Galvin JE
    Alzheimer Dis Assoc Disord; 2006; 20(4):302-10. PubMed ID: 17132978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.